Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors

被引：27
|
作者：
Morris, AAM [1 ]
Baudouin, S
Snow, MH
机构：
[1] Royal Victoria Infirm, Dept Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[2] Royal Victoria Infirm, Dept Anaesthet, Newcastle Upon Tyne, Tyne & Wear, England
[3] Royal Victoria Infirm, Dept Infect Dis, Newcastle Upon Tyne, Tyne & Wear, England
[4] Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
来源：
AIDS | 2001年 / 15卷 / 01期
关键词：
D O I：
10.1097/00002030-200101050-00027
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：140 / 141
页数：2
相关论文
共 50 条
  • [41] Voltammetric Methods Used in the Determination of Nucleoside Reverse Transcriptase Inhibitors
    Agin, Fatma
    Dogan, Inci Selin
    CURRENT PHARMACEUTICAL ANALYSIS, 2021, 17 (03) : 409 - 420
  • [42] Repurposing nucleoside reverse transcriptase inhibitors (NRTIs) to slow aging
    Brochard, Thomas
    Mcintyre, Rebecca L.
    Houtkooper, Riekelt H.
    Seluanov, Andrei
    Gorbunova, Vera
    Janssens, Georges E.
    AGEING RESEARCH REVIEWS, 2023, 92
  • [43] Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom
    Pedersen, OS
    Pedersen, EB
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1999, 10 (06): : 285 - 314
  • [44] Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy
    Lewis, W
    ANTIVIRAL THERAPY, 2005, 10 : M13 - M27
  • [45] Toxicity of non-nucleoside analogue reverse transcriptase inhibitors
    Kontorinis, N
    Dieterich, DT
    SEMINARS IN LIVER DISEASE, 2003, 23 (02) : 173 - 181
  • [46] Impact of Nucleoside Reverse Transcriptase Inhibitors on Coronary Heart Disease
    Mallon, Patrick W. G.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2014, 15 : S21 - S29
  • [47] Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors
    Patrick F. Smith
    Robert DiCenzo
    Gene D. Morse
    Clinical Pharmacokinetics, 2001, 40 : 893 - 905
  • [48] Clinical experience with non-nucleoside reverse transcriptase inhibitors
    Miller, V
    Staszewski, S
    Boucher, CAB
    Phair, JP
    AIDS, 1997, 11 : S157 - S164
  • [49] Clinical uses of non-nucleoside reverse transcriptase inhibitors
    Harris, M
    Montaner, JSG
    REVIEWS IN MEDICAL VIROLOGY, 2000, 10 (04) : 217 - 229
  • [50] Should non-nucleoside reverse transcriptase inhibitors be combined?
    Kappelhoff B.S.
    Huitema A.D.R.
    Beijnen J.H.
    Drugs in R & D, 2005, 6 (2) : 61 - 69
12345